|
10685332
|
Fox R
|
1999
|
Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.
|
|
10685333
|
Waggoner W
|
1999
|
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
|
|
10685334
|
Schally AV
|
1999
|
LH-RH analogues: I. Their impact on reproductive medicine.
|
|
10685525
|
Hacihanefioglu B
|
2000
|
Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome.
|
|
10685526
|
Felemban A
|
2000
|
Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.
|
|
10685546
|
Liu X
|
2000
|
Effects of recombinant human FSH (rhFSH), urinary purified FSH (uFSH), and hMG on small preantral follicles and tertiary follicles from normal adult and androgen-sterilized female mice.
|
|
10686193
|
Mantzoros CS
|
2000
|
Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome.
|
|
10686206
|
Rai R
|
2000
|
Polycystic ovaries and recurrent miscarriage--a reappraisal.
|
|
10689001
|
Lindheim SR
|
2000
|
Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology.
|
|
10689004
|
Witchel SF
|
2000
|
No association between body mass index and beta(3)-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenism.
|
|
10690875
|
Imani B
|
2000
|
Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
|
|
10693184
|
Plouffe L Jr
|
2000
|
Disorders of excessive hair growth in the adolescent.
|
|
10695100
|
Gupta S
|
1999
|
Polycystic ovarian syndrome: is community care appropriate?
|
|
10696281
|
Bray GA
|
1999
|
Etiology and pathogenesis of obesity.
|
|
10698182
|
Lara HE
|
2000
|
An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat.
|
|
10698183
|
Dissen GA
|
2000
|
Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat.
|
|
10703589
|
Fauser BC
|
2000
|
[Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders].
|
|
10707578
|
Sanaka M
|
2000
|
[Troglitazone for treatment of polycystic ovary syndrome].
|
|
10711825
|
Bukulmez O
|
2000
|
Leukocytes in ovarian function.
|
|
10714750
|
Chin D
|
2000
|
Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome.
|
|
10716298
|
Stener-Victorin E
|
2000
|
Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome.
|
|
10718837
|
Kokaly W
|
2000
|
Relapse of hirsutism following long-term successful treatment with oestrogen-progestogen combination.
|
|
10719843
|
Sun F
|
2000
|
The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats.
|
|
10720020
|
Villa V
|
2000
|
Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.
|
|
10720029
|
Chang PL
|
2000
|
Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
|
|
10730388
|
Rachev E
|
1999
|
[Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
|
|
10731530
|
Ciampelli M
|
2000
|
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.
|
|
10731531
|
Tartagni M
|
2000
|
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
|
|
10731532
|
Winters SJ
|
2000
|
Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.
|
|
10731533
|
Wu X
|
2000
|
Androgen excess contributes to altered growth hormone/insulin-like growth factor-1 axis in nonobese women with polycystic ovary syndrome.
|
|
10731534
|
Diamanti-Kandarakis E
|
2000
|
Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome.
|
|
10731545
|
Gallinelli A
|
2000
|
Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea.
|
|
10732317
|
Qin KN
|
2000
|
Expression of 17 beta-hydroxysteroid dehydrogenase type 5 in human ovary: a pilot study.
|
|
10733310
|
Toledo SP
|
2000
|
Inactivating mutations in the LH receptor-as rare as a hen with teethor as frequent as polycystic ovary syndrome?
|
|
10733311
|
McDonough PG
|
2000
|
Inactivating mutations in the LH receptor-as rare a a hen with teeth or as frequent as polycystic ovary syndrome?
|
|
10734677
|
B?rzashki I
|
1999
|
[Laparoscopic fenestration of the ovaries in sterility and the Stein-Leventhal syndrome--is it a modern fad or correct procedure].
|
|
10734678
|
Kolarov G
|
1999
|
[The use of the preparation Anteovin in dysfunctional uterine hemorrhages and PCOS].
|
|
10734682
|
Rachev E
|
1999
|
[Polycystic ovary syndrome. II. The current therapeutic approach].
|
|
10739813
|
Suikkari AM
|
2000
|
Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes.
|
|
10739820
|
Cibula D
|
2000
|
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.
|
|
10749978
|
Stead JD
|
2000
|
Allele diversity and germline mutation at the insulin minisatellite.
|
|
10751596
|
Vogeser M
|
2000
|
Corticosteroid-binding globulin and unbound serum cortisol in women with polycystic ovary syndrome.
|
|
10756492
|
Hagag P
|
2000
|
Diagnosis of polycystic ovary disease in obese women with a 24-hour hormone profile after buserelin stimulation.
|
|
10756770
|
Ghemigian A
|
1997
|
[The etiopathogenetic hypotheses in polycystic ovary].
|
|
10758797
|
Sengos C
|
2000
|
Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome.
|
|
10762292
|
Atiomo WU
|
2000
|
Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
|
|
10770198
|
Nordt TK
|
2000
|
Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
|
|
10770203
|
De Leo V
|
2000
|
Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.
|
|
10775522
|
Reuber M
|
2000
|
Valproate, polycystic ovary syndrome and the need for a prospective study.
|
|
10775648
|
Kaaijk EM
|
2000
|
Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.
|
|
10785214
|
Mathur RS
|
2000
|
Distinction between early and late ovarian hyperstimulation syndrome.
|
|
10785223
|
Pigny P
|
2000
|
Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
|
|
10785224
|
Cha KY
|
2000
|
Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.
|
|
10785225
|
M?derris II
|
2000
|
A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
|
|
10786401
|
Antoine JM
|
2000
|
[Therapeutic management of ovarian dystrophy and insufficiency in abortion disorders: recent data].
|
|
10792338
|
Spritzer PM
|
2000
|
Spironolactone as a single agent for long-term therapy of hirsute patients.
|
|
10792339
|
Wild S
|
2000
|
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
|
|
10796488
|
Hughes E
|
2000
|
Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.
|
|
10796690
|
Hughes E
|
2000
|
Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
|
|
10796718
|
Bayram N
|
2000
|
Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
|
|
10796746
|
Farquhar C
|
2000
|
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.
|
|
10799412
|
Godfrey KM
|
2000
|
Fetal nutrition and adult disease.
|
|
10802080
|
Takeuchi T
|
2000
|
Basal leptin concentrations in women with normal and dysfunctional ovarian conditions.
|
|
10804375
|
Dewailly D
|
2000
|
[Polycystic ovary syndrome].
|
|
10804539
|
Sozen I
|
2000
|
Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
|
|
10806662
|
Wang A
|
1998
|
[Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].
|
|
10813104
|
Doldi N
|
2000
|
Polycystic ovary syndrome: evidence for reduced 3 beta-hydroxysteroid dehydrogenase gene expression in human luteinizing granulosa cells.
|
|
10813106
|
Vicino M
|
2000
|
Predictive value of serum androstenedione basal levels on the choice of gonadotropin or laparoscopic ovarian electrocautery as ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.
|
|
10814527
|
Mu YM
|
2000
|
Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells.
|
|
10814602
|
Lakhani K
|
2000
|
Internal carotid artery haemodynamics in women with polycystic ovaries.
|
|
10817097
|
Piontek CM
|
2000
|
Appropriate clinical management of women taking valproate.
|
|
10817101
|
Rasgon NL
|
2000
|
Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.
|
|
10818406
|
Legro RS
|
2000
|
The genetics of obesity. Lessons for polycystic ovary syndrome.
|
|
10818407
|
Diamanti-Kandarakis E
|
2000
|
Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome.
|
|
10818412
|
Creatsas G
|
2000
|
Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
|
|
10821224
|
Lewy VD
|
1999
|
Determination of body composition in African-American children: validation of bioelectrical impedence with dual energy X-ray absorptiometry.
|
|
10831553
|
Morin-Papunen LC
|
2000
|
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.
|
|
10843164
|
Mather KJ
|
2000
|
Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
|
|
10852468
|
Wickenheisser JK
|
2000
|
Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
|
|
10856463
|
Kim LH
|
2000
|
Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility?
|
|
10856472
|
Timmerman-van Kessel EC
|
2000
|
A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
|
|
10856473
|
Kolodziejczyk B
|
2000
|
Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
|
|
10856495
|
Campo S
|
2000
|
Ovarian hyperstimulation after administration of triptorelin therapy to a patient with polycystic ovary syndrome.
|
|
10856497
|
Hacihanefioglu B
|
2000
|
Polycystic ovary syndrome nomenclature: chaos?
|
|
10858183
|
Lobo RA
|
2000
|
The importance of diagnosing the polycystic ovary syndrome.
|
|
10861555
|
Kumar A
|
2000
|
Induction of ovulation by clomiphene citrate in the Indian vespertilionid bat, Scotophilus heathi.
|
|
10869785
|
Sills ES
|
2000
|
Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes.
|
|
10870780
|
Vollenhoven B
|
2000
|
Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins.
|
|
10871644
|
Liao WX
|
2000
|
Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome.
|
|
10873116
|
Ben-Rafael Z
|
2000
|
Polycystic ovary syndrome: a single gene mutation or an evolving set of symptoms.
|
|
10873123
|
Sladkevicius P
|
2000
|
Advanced ultrasound examination in the management of subfertility.
|
|
10880731
|
Hern?ndez I
|
2000
|
Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome.
|
|
10887449
|
Bergfeld WF
|
2000
|
Hirsutism in women. Effective therapy that is safe for long-term use.
|
|
10891991
|
Isojarvi JI
|
2000
|
Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
|
|
10895282
|
Kinalski M
|
1999
|
[The effect of obesity on ovarian function. I. Serum insulin and insulin dependent protein concentrations in obese patients with polycystic ovary syndrome].
|
|
10895283
|
Kowalska I
|
1999
|
[The influence of obesity on ovarian function. II. Plasma leptin concentration in women with polycystic ovary syndrome].
|
|
10899496
|
van Hooff MH
|
2000
|
Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.
|
|
10899497
|
Romaguera J
|
2000
|
Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico.
|
|
10900588
|
Seale FG 4th
|
2000
|
Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
|
|
10901869
|
Eden JA
|
1999
|
A review of 1019 consecutive cases of polycystic ovary syndrome demonstrated by ultrasound.
|